摘要
目前已有较多对肝脏疾病的肠道微生态变化的研究成果,并且微生态制剂广泛应用于临床,但在终末期肾病患者的肠道微生态变化的研究方面则较少,至于这类患者中行腹膜透析者的肠道微生态状况则未见报道。本文通过复习国内、外的文献,进行归纳总结,并加以综述,初步从理论上论证腹膜透析与肠道微生态之关联性研究的可行性,并由此推论应用肠道微生态制剂可能有效降低此类患者腹膜炎的发生率。
At present, there have been many research achievements about the dynamic variability of intestinal microflora in hepatic patients and the microhioecological preparation has been widely used. However,the studing of the gut microbial ecology in End-stage renal disease is scarce, not to mention that cases who are accepting peritoneal dialysis（PD） therapy. In this paper, literatures about intestinal microflora published in China and abroad were collected and reviewed to theoretically proved the feasibility of discussing the interaction between PD and Gut microbial ecology. Eventually, we deduced that the using of microhioecological preparation may reduce the incidence of peritonitis in such examples.
出处
《复旦学报（医学版）》
CAS
CSCD
北大核心
2013年第3期375-378,共4页
Fudan University Journal of Medical Sciences
基金
浙江省教育厅科研项目(N20110429)~~
关键词
肠道微生态
慢性肝炎
终末期肾病
腹膜透析
肠道微生态制剂
gut microbial ecology
chronic hepatitis
ESRD （end-stage renal disease）
PD（peritoneal dialysis）
microbioecological preparation
